Mission and Process
The mission of the Coulter Translational Partnership (TP) Program at the University of Missouri is to increase the capacity and the pace of biomedical innovation that ultimately benefits patients and society by addressing unmet clinical needs. Bridge Funding awarded under the TP program is focused on bringing biomedical engineering solutions to the point at which they become attractive for follow-on funding to advance in the translational process. This is accomplished by de-risking proposed projects in aspects such as intellectual property and market opportunity, identifying and engaging early with potential partners with financing and product development capabilities, and then funding specific determinative experiments in a disciplined, managed process. This approach is based on the Stage-Gate® process and similar approaches used widely in industry.
The founding contributors to the Coulter Translational Partnership are the Wallace H. Coulter Foundation and the University of Missouri.